Home / Student & Public Resources / USPTO BCP Meetings

USPTO Biotech/Chemical Partnership (BCP) Meetings

In This Section

Biotech/Chem/Pharma (BCP) Customer Partnership Meeting - March 29, 2022

Mar 29, 2022, 14:40 PM by AIPLA Admin
Share your insights and experiences to improve patent prosecution in biotechnology areas at the next United States Patent and Trademark Office's (USPTO) Biotechnology, Chemical, and Pharmaceutical Customer Partnership (BCP) meeting.

BCP meetings are part of a long-standing partnership between the USPTO and its valued stakeholders. The partnership works to improve the quality of the USPTO's products and services.  

The meeting's discussion topics include:

  • Claim construction and doctrine of equivalents
  • Statutory provisions governing patent infringement: A practical analysis
  • Deferred subject matter eligibility response pilot program
  • Quality metrics
  • Explicit rationales in rejections under 35 U.S.C. 103
  • A systematic approach to 35 U.S.C. 112(b)
  • Sequence search

View meeting agenda

9:00 – 9:10 a.m. Welcome and opening remarks

  • Daniel Sullivan Director, TC1600, USPTO
  • Gary Jones Director, TC1600, USPTO

9:10 – 10:30 a.m. Claim Construction and Doctrine of Equivalents – A review for the Patent Office

  • Henry C. Su Trial Lawyer and Partner, Bradley Arant Boult Cummings LLP

10:30 – 10:40 a.m. Break

10:40 – 11:40 a.m. Statutory provisions governing patent infringement – A practical analysis

  • Christopher J. Harnett Shareholder, Maynard, Cooper & Gale in NYC

11:40 a.m. – 12:00 p.m. Deferred subject matter eligibility response (DSMER) pilot program

  • Daniel Kolker Supervisory Patent Examiner (SPE) TC1600, USPTO

12:00 – 1:00 p.m. Lunch

1:00 – 1:30 p.m. Patent Quality Metrics

  • Kathleen Bragdon Quality Assurance Specialist (mQAS) OPQA, USPTO

1:30 – 2:30 p.m. Providing explicit rationales in rejections under 35 U.S.C. 103

  • Lora Barnhart Driscoll Quality Assurance Specialist (TQAS) TC1600, USPTO

2:30 – 2:40 p.m. Break

2:40 – 3:10 p.m. Biological Sequence Searching

  • Christopher Babic Supervisory Patent Examiner (SPE) TC1600, USPTO

3:10 – 4:40 p.m. A systematic approach to 35 U.S.C. 112(b)

  • Gary Benzion Supervisory Patent Examiner (SPE)
  • Bennett Celsa Quality Assurance Specialist (TQAS)
  • Amjad Abraham Supervisory Patent Examiner (SPE)
  • Ashwin Mehta Review Quality Assurance Specialist (RQAS)
  • TC1600 and OPQA, USPTO

4:40 – 5:00 p.m. Closing remarks

  • TC1600 Directors, USPTO